Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Standard Biotools (LAB) Operating Expenses (2016 - 2026)

Standard Biotools has reported Operating Expenses over the past 16 years, most recently at $36.0 million for Q4 2025.

  • Quarterly Operating Expenses fell 3.77% to $36.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $167.5 million through Dec 2025, down 16.79% year-over-year, with the annual reading at $152.8 million for FY2025, 11.36% down from the prior year.
  • Operating Expenses was $36.0 million for Q4 2025 at Standard Biotools, down from $42.4 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $84.4 million in Q1 2024 and troughed at $28.9 million in Q1 2023.
  • The 5-year median for Operating Expenses is $38.8 million (2024), against an average of $42.7 million.
  • Year-over-year, Operating Expenses tumbled 46.54% in 2023 and then skyrocketed 192.2% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $48.1 million in 2021, then crashed by 32.91% to $32.3 million in 2022, then rose by 7.63% to $34.7 million in 2023, then grew by 7.76% to $37.4 million in 2024, then decreased by 3.77% to $36.0 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Operating Expenses are $36.0 million (Q4 2025), $42.4 million (Q3 2025), and $36.3 million (Q2 2025).